MENU
+Compare
CNADF
Stock ticker: OTC
AS OF
Apr 10 closing price
Price
$0.06
Change
-$0.00 (-0.00%)
Capitalization
4.49M

CNADF CANADABIS CAP INC Forecast, Technical & Fundamental Analysis

CanadaBis Capital Inc is a vertically integrated cannabis company... Show more

CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CNADF with price predictions
Sep 17, 2025

CNADF's RSI Indicator is staying in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNADF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.364) is normal, around the industry mean (17.169). P/E Ratio (11.571) is within average values for comparable stocks, (74.138). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.888). CNADF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.688) is also within normal values, averaging (46.994).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNADF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
PO Box 850
Phone
+1 888 784-4621
Employees
N/A
Web
https://www.canadabis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UAMY5.600.28
+5.26%
United States Antimony Corp
YOUL1.740.02
+1.16%
Youlife Group Inc.
TTD45.370.47
+1.06%
Trade Desk (The)
GRND15.54-0.19
-1.21%
Grindr
SINT3.93-0.10
-2.60%
SiNtx Technologies Inc.

CNADF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with BJTRF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then BJTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
BJTRF - CNADF
61%
Loosely correlated
N/A
STEK - CNADF
26%
Poorly correlated
+7.81%
PLSH - CNADF
21%
Poorly correlated
+4.84%
HLN - CNADF
15%
Poorly correlated
+1.29%
PLNH - CNADF
5%
Poorly correlated
-8.32%
More

Groups containing CNADF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
Pharmaceuticals
category (385 stocks)
2%
Poorly correlated
-0.02%
Pharmaceuticals: Generic
category (221 stocks)
0%
Poorly correlated
+0.51%